Managing Pain and Cognitions in Older Adults With Mild Cognitive Impairment or Memory Related Problems and Chronic Pain

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04044183
Collaborator
(none)
70
1
2
14.6
4.8

Study Details

Study Description

Brief Summary

We aim to conduct a pilot randomized controlled trial comparing 2 symptom management programs for older adults with self-reported memory problems and chronic pain, Active Brains 1 and Active Brains 2. We will assess how each program may help in improving coping with pain and coping with cognitive functioning. We will explore feasibility, acceptability, and credibility and within group changes in physical, emotional and cognitive functioning.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Active Brains 1
  • Behavioral: Active Brains 2
N/A

Detailed Description

We aim to conduct a pilot randomized controlled trial comparing 2 symptom management programs for older adults with self-reported memory problems and chronic pain: Active Brains 1 Active Brains 2. We will assess how each program may help in improving coping with pain and coping with cognitive functioning. We will explore feasibility, acceptability, and credibility and within group changes in physical, emotional and cognitive functioning.

Each group meets for 8 90 minute sessions over a secure video platform. Each group has 5-8 participants. Participants receive a treatment manual. There are 2 assessment points: baseline, and post program. Assessments involve questionnaires, a walk test, and objective step count with ActiGraphs for 1 week.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Active Brains: Managing Pain and Cognitions in Older Adults With Mild Cognitive Impairment (MCI) or Memory Related Problems (MRP) and Chronic Pain
Actual Study Start Date :
Sep 15, 2019
Anticipated Primary Completion Date :
Dec 1, 2020
Anticipated Study Completion Date :
Dec 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Active Brains

Active Brains uses a multimodal approach to introduce and reinforce new skills, including didactics, in-session activities, discussions, and weekly practice assignments (homework). The Active Brains sessions reflect a purposeful integration of the three treatment approaches (relaxation methods, stress appraisal & coping, and growth enhancement). The format is an 8-week program with weekly meetings and a focus on relaxation response strategies, cognitive behavioral training, positive psychology and mind-body interactions. Active Brains 1 uses a digital monitoring device (i.e., Fitbit) for recording of physical activity.

Behavioral: Active Brains 1
Active Brains uses a multimodal approach to introduce and reinforce new skills, including didactics, in-session activities, discussions, and weekly practice assignments (homework). The Active Brains sessions reflect a purposeful integration of the three treatment approaches (relaxation methods, stress appraisal & coping, and growth enhancement). The format is an 8-week program with weekly meetings and a focus on relaxation response strategies, cognitive behavioral training, positive psychology and mind-body interactions. Active Brains 1 uses a digital monitoring device (i.e., Fitbit) for recording of physical activity.

Behavioral: Active Brains 2
This active comparison condition controls for the effect of time spent, group member support/feedback, and interventionist support/feedback. The original HEP was adapted to provide population-specific information on chronic pain and MCI/MRP symptoms. Participants also receive lifestyle education consistent from public health recommendations and standards for health promotion (e.g., "Sleep", "Nutrition", "Healthy Weight", and "Medical appointments"). The HEP program consists on 8 group sessions (each session is 90 minutes) that occur concurrently with the active intervention condition. The HEP is conducted in the same format as Active Brains-Fitbit but are not taught the mind-body, walking, or cognitive-behavioral skills. HEP participants are encouraged to set lifestyle goals instead of quota-based walking goals aided by the Fitbit as in the Active Brains-Fitbit condition.

Placebo Comparator: Active Brains 2

This active comparison condition controls for the effect of time spent, group member support/feedback, and interventionist support/feedback. The original HEP was adapted to provide population-specific information on chronic pain and MCI/MRP symptoms. Participants also receive lifestyle education consistent from public health recommendations and standards for health promotion (e.g., "Sleep", "Nutrition", "Healthy Weight", and "Medical appointments"). The HEP program consists on 8 group sessions (each session is 90 minutes) that occur concurrently with the active intervention condition. The HEP is conducted in the same format as Active Brains-Fitbit but are not taught the mind-body, walking, or cognitive-behavioral skills. HEP participants are encouraged to set lifestyle goals instead of quota-based walking goals aided by the Fitbit as in the Active Brains-Fitbit condition.

Behavioral: Active Brains 1
Active Brains uses a multimodal approach to introduce and reinforce new skills, including didactics, in-session activities, discussions, and weekly practice assignments (homework). The Active Brains sessions reflect a purposeful integration of the three treatment approaches (relaxation methods, stress appraisal & coping, and growth enhancement). The format is an 8-week program with weekly meetings and a focus on relaxation response strategies, cognitive behavioral training, positive psychology and mind-body interactions. Active Brains 1 uses a digital monitoring device (i.e., Fitbit) for recording of physical activity.

Behavioral: Active Brains 2
This active comparison condition controls for the effect of time spent, group member support/feedback, and interventionist support/feedback. The original HEP was adapted to provide population-specific information on chronic pain and MCI/MRP symptoms. Participants also receive lifestyle education consistent from public health recommendations and standards for health promotion (e.g., "Sleep", "Nutrition", "Healthy Weight", and "Medical appointments"). The HEP program consists on 8 group sessions (each session is 90 minutes) that occur concurrently with the active intervention condition. The HEP is conducted in the same format as Active Brains-Fitbit but are not taught the mind-body, walking, or cognitive-behavioral skills. HEP participants are encouraged to set lifestyle goals instead of quota-based walking goals aided by the Fitbit as in the Active Brains-Fitbit condition.

Outcome Measures

Primary Outcome Measures

  1. Change in Client Satisfaction Questionnaire 3-Item (CSQ-3) [8 Weeks]

    Items are summed to generate a total score; scores range from 3 to 12, with higher values indicating higher satisfaction

Secondary Outcome Measures

  1. Adherence to DMD (digital monitoring device) [0 Weeks, 8 Weeks]

    Rate of participant's use of DMD throughout the study

  2. Adherence to Homework [0 Weeks, 8 Weeks]

    Rate of participant's completion of homework assigned throughout the study

  3. Therapist Adherence to Session [0 Weeks, 8 Weeks]

    Rate of interventionist's delivering the programs by following the established session topics and skills

  4. Feasibility of Quantitative Measures [0 Weeks, 8 Weeks]

    Rate of participant's completion of self-report measures

  5. Rescue (Non-Narcotic) Analgesic Use [0 Weeks]

    Single-item question on demographics form

  6. Narcotic Analgesic Use [0 Weeks]

    Single-item question on demographics form

  7. Credibility and Expectancy Questionnaire (CEQ) [0 Weeks]

    Rate of participant's expectations and believed credibility for program, with higher ratings indicating more belief that the program is logical and will help with the intended outcome

  8. Montreal Cognitive Assessment (MoCA) [0 Weeks, 8 Weeks]

    Assesses several cognitive domains and detection of mild cognitive impairment (MCI), with scores ranging from 0-30 and lower scores indicating greater cognitive decline

  9. Godin Leisure-Time Exercise Questionnaire [0 Weeks, 8 Weeks]

    Rate of participant's leisure time and physical activity levels by indicating how many days per week are spent doing the activity for more than 15 minutes

  10. Measure of Current Status (MOCS-A) [0 Weeks, 8 Weeks]

    Rate of a participant's self-reported perceived stress self-management skills, with items ranging from 0-4 and a total score ranging from 0-52, and higher scores reflecting more usage of stress self-management skills

  11. The Measurement of Everyday Cognition (eCog) [0 Weeks, 8 Weeks]

    Rate of participant's cognitively mediated functional abilities, with items ranging from 1-5, with a total score ranging from 12-60, with higher scores indicating greater cognitive decline

  12. Numerical Rating Scale [0 Weeks, 8 Weeks]

    Rate of a participant's pain at rest and with activity using a Likert scale with 0 being no pain and 10 being the worst possible pain

  13. The Cognitive and Affective Mindfulness Scale - Revised (CAMS-R) [0 Weeks, 8 Weeks]

    Rate of a participant's broad conceptualization of mindfulness, items range from 1-4 and scores range from 12-48, with higher values reflecting higher levels of mindfulness

  14. WHO Disability Assessment Schedule 2.0 [0 Weeks, 8 Weeks]

    Rate of a participant's health and disability, with items ranging from 0-4, and higher scores reflecting greater disability

  15. The Gratitude Questionnaire (GQ-6) [0 Weeks, 8 Weeks]

    Rate of a participant's proneness to experience gratitude in daily life, with items ranging from 1-7, total scores ranging from 6-24, and a higher score indicating greater amount of gratitude

  16. PROMIS Physical Function [0 Weeks, 8 Weeks]

    Rate of a participant's capability rather than performance of physical activities, with items ranging from 1-4, and total scores ranging from 8-40, with a higher score reflecting greater physical function

  17. PROMIS Emotional Support [0 Weeks, 8 Weeks]

    Rate of a participant's perceived feelings of being cared and values for as an individual, with items ranging from 1-5, total scores ranging from 4-20, and a higher score indicating higher perceived social support

  18. PROMIS Depression [0 Weeks, 8 Weeks]

    Rate of a participant's negative mood, social cognition, and views of self, with items ranging from 1-5, total scores ranging from 8-40, and a higher score reflecting higher levels of depression

  19. PROMIS Anxiety [0 Weeks, 8 Weeks]

    Rate of a participant's fear, anxious, hyper arousal, and somatic symptoms pertaining to arousal, with items ranging from 1-5, total scores ranging from 8-40, and a high score reflecting higher levels of anxiety

  20. Pain Catastrophizing Scale (PCS) [0 Weeks, 8 Weeks]

    Rate of a participant's pain experience, with items ranging from 0-4, and total scores ranging from 0-52, with higher scores indicating higher levels of pain catastrophizing

  21. UCLA Loneliness Scale [0 Weeks, 8 Weeks]

    Rate of a participant's feelings of loneliness and social isolation and items range from 0-3, with a higher score reflecting greater feelings of loneliness, with total scores ranging from 0-24

  22. Pain Self Efficacy Questionnaire (PSEQ) [0 Weeks, 8 Weeks]

    Rate of a participant's confidence to do various activities despite their pain, with items ranging from 0-6, and a higher score showing greater levels of confidence with pain self-efficacy, with total scores ranging from 0-60

  23. The Pittsburgh Sleep Quality Index (PSQI) [0 Weeks, 8 Weeks]

    Rate of a participant's sleep quality and patterns of sleep with total scores ranging from 0 to 21, with higher scores indicating greater sleep disturbance

  24. Tampa Kinesiophobia Scale [0 Weeks, 8 Weeks]

    Rate of a participant's fear of movement, with items ranging from 1-4, and a total scores ranging from 17-68, and higher scores indicating higher levels of fear of movement

  25. Chronic Pain Acceptance Questionnaire [0 Weeks, 8 Weeks]

    Rate of a participant's acceptance of chronic pain, with scores ranging from 0-6, with the total score ranging from 0-48, and higher scores indicating higher levels of acceptance of chronic pain

  26. Self-Compassion Scale (SCS) [0 Weeks, 8 Weeks]

    Rate of a participant's amount of self-compassion, with items ranging from 1-5, and total scores ranging from 12-60 and higher scores indicating higher levels of self-compassion

  27. Demographics [0 Weeks]

    Questionnaire that asks individuals to report on: date of birth, gender, weight, height, handedness, ethnicity, race, martial status, education level, employment status, type of job, income, pain diagnoses, length of chronic pain, other medical conditions, mental health conditions, pain medications, cognitive preservations

  28. Additional Exit Interview Questions [8 Weeks]

    Asks about specific components related to the program and the helpfulness of the program for chronic pain and cognition

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male and female patients, age 60 years or older

  • Have nonmalignant chronic pain for more than 3 months

  • Has MCI or subjective memory related problems

  • Able to perform a 6-minute walk test at an accelerated pace

  • Owns a smartphone with Bluetooth 4.0

  • Willingness and ability to participate in the Active Brains intervention and to comply with the requirements of the study protocol (including weekly sessions and Fitbit use)

  • Free of concurrent psychotropic or pain medication for at least 2 weeks prior to initiation of treatment, OR stable on current psychotropic or pain medication for a minimum of 6 weeks and willing to maintain a stable dose

  • Cleared by a medical doctor for study participation

  • Leads a sedentary lifestyle

Exclusion Criteria:
  • Diagnosed with medical illness expected to worsen in the next 6 months

  • Serious mental illness or instability for which hospitalization may be likely in the next 6 months

  • Current suicidal ideation reported on self-report

  • Lifetime history of schizophrenia, bipolar disorder, or other psychotic disorder, or substance dependence

  • Current substance use disorder, within the past 6 months

  • Practice of yoga/meditation, or other mind-body techniques that elicit the relaxation response, once per week for 45 minutes or more within the last 3 months or less

  • Regular use of Fitbit in the last 3 months

  • Engagement in regular intensive physical exercise for >30 minute daily

  • Unable to walk without use of assistance (e.g., wheelchair, walker)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Massachusetts General Hospital Boston Massachusetts United States 02114

Sponsors and Collaborators

  • Massachusetts General Hospital

Investigators

  • Principal Investigator: Ana-Maria Vranceanu, PhD, Massachusetts General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ana-Maria Vranceanu, PhD, Associate Professor/Director, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT04044183
Other Study ID Numbers:
  • 2018P002152
First Posted:
Aug 5, 2019
Last Update Posted:
Sep 23, 2020
Last Verified:
Sep 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ana-Maria Vranceanu, PhD, Associate Professor/Director, Massachusetts General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 23, 2020